Distillate Capital Partners’s CVS Health CVS Stock Holding History

Distillate Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-159	Closed	-$12.7K	–	106
2024 Q1	$12.7K	Sell	159 -14	-8%	-$1.07K	2.13%	38
2023 Q4	$13.7K	Hold	173	–	–	2.97%	14
2023 Q3	$12.1K	Buy	173 +28	+19%	+$1.98K	3.05%	15
2023 Q2	$10K	Buy	145 +24	+20%	+$1.71K	3.24%	23
2023 Q1	$8.99K	Buy	121 +20	+20%	+$1.68K	2.31%	31
2022 Q4	$9.41K	Sell	101 -115,144	-100%	-$11.1M	0.87%	85
2022 Q3	$11.3M	Sell	115,245 -8,119	-7%	-$804K	1.51%	10
2022 Q2	$11.4M	Buy	123,364 +17,528	+17%	+$1.71M	1.63%	11
2022 Q1	$10.7M	Buy	+105,836	New	+$11.1M	1.52%	10

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Distillate Capital Partners's CVS Position: Q2 2024 in Review

Distillate Capital Partners sold out of CVS Health (CVS) in Q2 2024, closing a stake of 159 shares — an estimated $12.7K sold.

Distillate Capital Partners first reported a position in CVS in Q1 2022 and held it in 9 quarters. The position peaked at $11.4M in Q2 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Distillate Capital Partners reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
Distillate Capital Partners sold 159 CVS Health shares in Q2 2024, an estimated $12.7K.
Distillate Capital Partners first reported a position in CVS Health in Q1 2022 and held it in 9 quarters.
Distillate Capital Partners's CVS Health position peaked at $11.4M in Q2 2022.
1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Distillate Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.